Refreshed just now
Biotech3 days
Vertical
- All verticals
- Space
- Energy
- Quantum
- Robotics
- Cybersecurity
- Biotechnology
- Defense Tech
- Artificial Intelligence
In the News
5 stories · past 3 days55h agoSTATSTAT+: FDA rejects lung cancer treatment ivonescimab from Summit TherapeuticsThe FDA issued a complete rejection of Summit Therapeutics and Akeso's lung cancer drug ivonescimab because it did not show an overall survival benefit despite slowing disease progression.1 outletBiotech YesterdayAnthropicLLMs and bioriskAnthropic's Institute publishes internal and public-benchmark evidence that AI is accelerating its own development, and argues that recursive self-improvement could arrive sooner than institutions expect and that a verifiable coordinated slowdown should be an option. BiotechAI236 linked12 articles
- YesterdayAnthropicPolicy on the AI Exponential
- YesterdayAnthropicNatural Language Autoencoders
- YesterdayAnthropicInvestigating unintended model actions in our evaluations and internal use
- YesterdayAnthropicResponsible Scaling Policy Version 3.0
- YesterdayAnthropicTrustworthy agents in practice
- YesterdayAnthropicPickupThoughts on America’s AI Action Plan
- YesterdayAnthropicUnderstanding and addressing AI harms
- YesterdayAnthropicTeaching Claude why
- YesterdayAnthropicPetri: An open-source AI auditing tool
- YesterdayAnthropicLLMs and biorisk
- YesterdayAnthropicAnthropic’s Transparency Hub
- YesterdayAnthropicEarliestWhen AI builds itself
2d agoNextgov/FCWNational Cancer Institute teases AI-assisted cancer care records retrievalThe National Cancer Institute is weighing an early-stage "Every Patient" initiative to capture cancer data on every U.S. cancer patient using AI, alongside a $200 million AI-enabled therapeutic cancer vaccine effort with the Foundation for the NIH.1 outletBiotechAI5 linked 2d agoSTATSTAT+: HHS plans funding for research into ibogaine for PTSDSTAT reports that HHS plans to fund research into ibogaine for PTSD, though the full story is paywalled and only a newsletter preview is available.1 outletBiotech2 linked 2d agoPR NewswireArmata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate UpdateArmata Pharmaceuticals received $3.7 million in additional DoW non-dilutive funding through MTEC for AP-SA02 Phase 3 execution, bringing cumulative award funding to about $32.4 million.1 outletBiotech
On the Hill
Congress, the White House and agencies12Ahead
Tuesday, Nov 17
Wednesday, Nov 18
9:45 AMCongressSenate Health, Education, Labor, and PensionsThe Senate HELP Committee has scheduled a business meeting to consider five executive nominees, including Heidi Overton for FDA Commissioner and James O'Neill for NSF Director.BiotechDetails6 linked 10:00 AMCongressSenate Commerce, Science, and TransportationThe Senate Commerce Committee scheduled a November 2026 business meeting to mark up a broad slate of telecommunications, aquaculture, semiconductor, biosecurity, aviation and science bills along with several executive nominations.S.69S.2586S.2883S.3301S.3741S.3954S.4256S.5251S.5332S.5508S.5663Trucker Bathroom Access ActCyberBiotechDetails17 linked 11:59 PMAgencyFDAFDA's draft guidance on potency assessment for active immunotherapy products is open for public comment under docket FDA-2026-D-8561 until November 19, 2026.Comment deadlineBiotechDetails
Thursday, Nov 19
2:00 PMCongressHouse Foreign Affairs East Asia and Pacific SubcommitteeThe House Foreign Affairs East Asia and Pacific Subcommittee convened a hearing on China's pharmaceutical supply chain dominance, calling U.S. Pharmacopeia, the Coalition for a Prosperous America and the Council on Foreign Relations to testify.Dr. Ron Piervincenzi · Mr. Andrew Rechenberg · Mr. Thomas BollykyBiotechDetails
Sunday, Nov 22
Friday, Nov 27
Tuesday, Jan 5
Monday, Jan 11
Friday, Jan 15
11:59 PMAgencyHealth and Human Services DepartmentCDC opened a Request for Information seeking public comment on a proposed target product profile describing minimal and optimal attributes for West Nile virus monoclonal antibody prophylaxis, with comments due January 15, 2027.Comment deadlineBiotechDetails1 linked
Recent
Friday, Nov 13
2d agoCongressHouse Select Committee on the CCPThe House Select Committee on China released a bipartisan report using four case studies to show how Beijing's state-directed industrial policy eroded US manufacturing in biomanufacturing, aerospace, semiconductors and machine tools.BiotechDetails20 linked
Wednesday, Nov 11
3d agoAgencyHealth and Human Services DepartmentFDA announced a draft guidance giving sponsors recommendations for early-phase IND protocols for solid tumor drugs and biologics, with comments due January 11, 2027.BiotechDetails5 linked
Nothing from this branch in view.
Times ET
Contracts
Solicitations, SBIR topics, grants and awards3RFPADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)2d agoARPA-H seeks proposals for SURPASS, a simulation-augmented real-time adaptive seamless trial platform, under solicitation ARPA-H-SOL-26-164.Closes in 15 daysARPA-H-SOL-26-164BiotechLifecycle10 linked GrantNational Institutes of Health11d agoNIH seeks applications for a U19 systems biology program on infection, inflammation and chronic disease, with a $26 million ceiling.$26M ceilingCloses in 95 daysRFA-AI-28-014BiotechLifecycle12 linked GrantNational Institutes of Health12d agoNIH seeks applications for translational genome editing and biologic therapy development for Alzheimer's-related dementias, with a $6 million ceiling.$6M ceilingCloses in 694 daysRFA-NS-28-012BiotechLifecycle12 linked